New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 21, 2024 - Coherus announced the launch of Udenyca Onbody (pegfilgrastim-cbqv), a biosimilar to Amgen’s Neulasta® OnPro® (pegfilgrastim).
Download PDF
Return to publications
